Cargando…

Metachronous cutaneous squamous cell carcinoma in a young patient as the only presenting symptom to uncover Lynch syndrome with MLH1 Germline mutation

BACKGROUND: Cutaneous malignancies are rare complications of Lynch syndrome and can include Muir-Torre and Turcot syndromes that are associated with sebaceous gland tumors and keratoacanthomas. The incidence and clinical course of cutaneous squamous cell carcinoma have not been well documented in Ly...

Descripción completa

Detalles Bibliográficos
Autores principales:	Khaddour, Karam, Fields, Ryan C., Ansstas, Michael, Rosman, Ilana S., Ansstas, George
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2020
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7670704/ https://www.ncbi.nlm.nih.gov/pubmed/33292409 http://dx.doi.org/10.1186/s13053-020-00155-w

Ejemplares similares

Clinical outcomes and longitudinal circulating tumor DNA changes after treatment with nivolumab and olaparib in immunotherapy relapsed melanoma with detected homologous recombination deficiency
por: Khaddour, Karam, et al.
Publicado: (2021)

Rapid and sustained response to immune checkpoint inhibition in cutaneous squamous cell carcinoma after allogenic hematopoietic cell transplant for sézary syndrome
por: Khaddour, Karam, et al.
Publicado: (2019)

Normalization of electroretinogram and symptom resolution of melanoma-associated retinopathy with negative autoantibodies after treatment with programmed death-1 (PD-1) inhibitors for metastatic melanoma
por: Khaddour, Karam, et al.
Publicado: (2021)

Case Report: Stereotactic body radiation treatment for immunotherapy escaped oligometastatic progression in cutaneous melanoma and merkel cell carcinoma
por: Khaddour, Karam, et al.
Publicado: (2023)

Induced Remission of Metastatic Squamous Cell Carcinoma with an Immune Checkpoint Inhibitor in a Patient with Recessive Dystrophic Epidermolysis Bullosa
por: Khaddour, Karam, et al.
Publicado: (2020)

The Landscape of Novel Therapeutics and Challenges in Glioblastoma Multiforme: Contemporary State and Future Directions
por: Khaddour, Karam, et al.
Publicado: (2020)

BRAF-MEK inhibitors as steroid-sparing bridge prior to checkpoint blockade therapy in symptomatic intracranial melanoma
por: Khaddour, Karam, et al.
Publicado: (2021)

Lynch Syndrome Associated with Two MLH1 Promoter Variants and Allelic Imbalance of MLH1 Expression
por: Hesson, Luke B, et al.
Publicado: (2015)

Melanoma Targeted Therapies beyond BRAF-Mutant Melanoma: Potential Druggable Mutations and Novel Treatment Approaches
por: Khaddour, Karam, et al.
Publicado: (2021)

Case report: Real-world experience using a personalized cancer-specific circulating tumor DNA assay in different metastatic melanoma scenarios
por: Khaddour, Karam, et al.
Publicado: (2022)

Lynch syndrome-associated endometrial carcinoma with MLH1 germline mutation and MLH1 promoter hypermethylation: a case report and literature review
por: Yokoyama, Takanori, et al.
Publicado: (2018)

A novel germline MLH1 mutation causing Lynch Syndrome in patients from the Republic of Macedonia
por: Hiljadnikova-Bajro, Marija, et al.
Publicado: (2012)

MLH1 germline mutation associated with Lynch syndrome in a family followed for more than 45 years
por: Momma, Tomoyuki, et al.
Publicado: (2019)

Successful administration of sequential TVEC and pembrolizumab followed by Temozolomide in immunotherapy refractory intracranial metastatic melanoma with acquired B2M mutation
por: Khaddour, Karam, et al.
Publicado: (2020)

Addendum: Successful administration of sequential TVEC and pembrolizumab followed by Temozolomide in immunotherapy refractory intracranial metastatic melanoma with acquired B2M mutation
por: Khaddour, Karam, et al.
Publicado: (2023)

Relationship of lower uterine segment cancer with Lynch syndrome: A novel case with an hMLH1 germline mutation
por: MASUDA, KENTA, et al.
Publicado: (2012)

Contribution of MLH1 constitutional methylation for Lynch syndrome diagnosis in patients with tumor MLH1 downregulation
por: Pinto, Diana, et al.
Publicado: (2018)

Germline MLH1, MSH2 and MSH6 variants in Brazilian patients with colorectal cancer and clinical features suggestive of Lynch Syndrome
por: Schneider, Nayê Balzan, et al.
Publicado: (2018)

A rare large duplication of MLH1 identified in Lynch syndrome
por: Kumar, Abhishek, et al.
Publicado: (2021)

Isolated MLH1 Loss by Immunohistochemistry Because of Benign Germline MLH1 Polymorphisms
por: Bosch, Dustin E., et al.
Publicado: (2022)

A novel MLH1 intronic variant in a young Japanese patient with Lynch syndrome
por: Kiyozumi, Yoshimi, et al.
Publicado: (2018)

Structure of the human MLH1 N-terminus: implications for predisposition to Lynch syndrome
por: Wu, Hong, et al.
Publicado: (2015)

A Chinese family affected by lynch syndrome caused by MLH1 mutation
por: Jia, Shuqin, et al.
Publicado: (2018)

MLH1 Promoter Methylation Could Be the Second Hit in Lynch Syndrome Carcinogenesis
por: Carnevali, Ileana Wanda, et al.
Publicado: (2023)

Cutaneous Squamous Cell Carcinoma in Lynch Syndrome — An Overlooked Association
por: Moorthy, Vivek, et al.
Publicado: (2021)

Novel Mutations in MLH1 and MSH2 Genes in Mexican Patients with Lynch Syndrome
por: Moreno-Ortiz, Jose Miguel, et al.
Publicado: (2016)

MLH1 Ile219Val Polymorphism in Argentinean Families with Suspected Lynch Syndrome
por: Dominguez-Valentin, Mev, et al.
Publicado: (2016)

Functional Characterization of a Missense Variant of MLH1 Identified in Lynch Syndrome Pedigree
por: Zaib, Tahir, et al.
Publicado: (2020)

Discordant immunohistochemistry in an unusual MLH1 gene variant in a case of Lynch syndrome
por: Nagabhushana, Prerana, et al.
Publicado: (2021)

Genome sequencing identifies complex structural MLH1 variant in unsolved Lynch syndrome
por: Witt, Dennis, et al.
Publicado: (2023)

Prolonged response of recurrent IDH-wild-type glioblastoma to laser interstitial thermal therapy with pembrolizumab
por: Hwang, Helen, et al.
Publicado: (2022)

A Novel Germline MLH1 In-Frame Deletion in a Slovenian Lynch Syndrome Family Associated with Uncommon Isolated PMS2 Loss in Tumor Tissue
por: Klančar, Gašper, et al.
Publicado: (2020)

A novel germline mutation in hMLH1 in three Korean women with endometrial cancer in a family of Lynch syndrome: case report and literature review
por: Jung, Youn-Joon, et al.
Publicado: (2021)

A predictive model of metachronous colorectal cancer occurrence in Lynch syndrome
por: Bertario, Lucio, et al.
Publicado: (2010)

Treatment with Tumor-Treating Fields Therapy and Pulse Dose Bevacizumab in Patients with Bevacizumab-Refractory Recurrent Glioblastoma: A Case Series
por: Ansstas, George, et al.
Publicado: (2016)

Endometrioid endometrial cancer “recurring” as high-grade serous adenocarcinoma in the inguinal lymph nodes in a patient with germline MLH1 mutated Lynch syndrome: consequence or coincidence?
por: Jiang, Wei, et al.
Publicado: (2019)

The G67E mutation in hMLH1 is associated with an unusual presentation of Lynch syndrome
por: Clyne, M, et al.
Publicado: (2009)

Somatic mosaicism by a de novo MLH1 mutation as a cause of Lynch syndrome
por: Geurts‐Giele, Willemina R., et al.
Publicado: (2019)

Computational and cellular studies reveal structural destabilization and degradation of MLH1 variants in Lynch syndrome
por: Abildgaard, Amanda B, et al.
Publicado: (2019)

Retracted: Functional Characterization of a Missense Variant of MLH1 Identified in Lynch Syndrome Pedigree
por: Markers, Disease
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_1hp49ggueu35g63g8fp1eidbqo